Data - AI The Road to AI Adoption in Medical Imaging: Deployment Pathways & Hurdles AI Deployment in Medical Imaging: Development Pathways So far, a prominent mechanism for AI deployment into clinics has been via medical imaging companies developing first-party algorithms that are ...
Cross-sector Accelerating R&D Pipeline With LLMS And Generative AI In Pharma: Opportunities & Common Pitfalls 5 Opportunities for LLMS and Generative AI in Pharma R&D Opportunity n°1: Increasing Efficiency in Drug Discovery As recent partnerships have shown (e.g., Isomorphic Labs with Novartis and ...
Healthcare GLP-1 Agonists in Addiction Treatments: Shrinking Cravings and Expanding Indications to Substance Use Disorders? GLP-1 Success Story GLP-1 agonists (also called GLP-1RAs), and related drugs like dual agonists of gastric inhibitory polypeptide (GIP)/GLP-1, have revolutionized obesity treatment by demonstrating ...
Cross-sector Why the healthcare industry should learn more about decentralized AI? What is decentralized AI? Decentralized AI is a system where data processing and machine learning occur across multiple locations instead of relying on a single, central repository. Although counter ...
Healthcare Vaccination, a solution to climate change’s health impacts? How climate change effects our health There are 15 metrics for measuring the impact of climate change on our human health according to the Lancet Countdown on health and climate change. They are ...
Energy - Environment - Mobility Planetary Boundaries: How to Go Beyond Carbon Impact Reduction with R&D Strategies? Planetary boundaries as safeguards for sustainable living in a safe ecosystem Earth is a balanced system that has been significantly disrupted by human activity since the 19th century and the ...
Healthcare The Challenges of Democratizing Clinical Research in General Hospitals in France How Are the Legislative and Regulatory Frameworks Governing Clinical Research Evolving in France? Since the 1958 Debré Ordinance, medical research has been recognized as a fundamental mission of ...
Healthcare State of the Art on Advances and Challenges in the Management of Patients with Alzheimer’s Disease Challenge 1: Developing Treatments to Cure or Slow the Progression of Alzheimer’s Disease In France, four medications are available to treat cognitive symptoms in Alzheimer’s patients, but they ...
Healthcare Unlocking the radiopharmaceuticals market: 3 challenges to overcome What are radiopharmaceuticals? A radiopharmaceutical is a drug composed of three building blocks: a radioactive isotope (radioisotope), a targeting molecule, and a linker that binds them. The ...
Healthcare What are the latest advances in aging research and drug discovery? What are the main challenges in aging research and drug R&D? Challenge n°1: Understand the complex nature of aging Aging is a complex process influenced by a combination of environmental and ...